X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/rivus-pharmaceuticals-announces-completion-of-enrollment-in-phase-2a-humain-trial-of-hu6-302026834.html
https://www.prnewswire.com/news-releases/rivus-pharmaceuticals-announces-expansion-of-hu6-clinical-program-and-new-leadership-appointments-301988369.html
https://www.prnewswire.com/news-releases/phase-2a-study-of-hu6-rivus-pharmaceuticals-investigational-controlled-metabolic-accelerator-demonstrates-clinical-benefit-in-patients-with-high-body-mass-index-and-nonalcoholic-fatty-liver-disease-301949019.html
https://www.prnewswire.com/news-releases/rivus-pharmaceuticals-to-present-results-from-a-phase-2a-trial-evaluating-its-controlled-metabolic-accelerator-hu6-at-the-american-association-for-the-study-of-liver-diseases-aasld2022-meeting-301668553.html
https://www.pharmaceutical-technology.com/news/rivus-development-obesity-treatment/
https://www.fiercebiotech.com/biotech/rivus-raises-132m-series-b-drug-prospects-obesity-nash-heat
https://www.prnewswire.com/news-releases/rivus-pharmaceuticals-closes-132-million-series-b-financing-to-advance-hu6-for-the-treatment-of-obesity-and-cardio-metabolic-disorders-301630391.html
https://www.fiercebiotech.com/biotech/rivus-throws-down-mid-stage-liver-fat-data-quest-to-climb-nash-mountain
https://www.prnewswire.com/news-releases/rivus-pharmaceuticals-announces-positive-results-from-phase-1-trial-of-lead-candidate-hu6-demonstrating-safety-efficacy-in-key-targets-for-multiple-cardio-metabolic-diseases-301412536.html
Market Place
Share 
